Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Notice Of Intent To Sole Source - Commercial Packaging And Validation For The Arakoda (Tafenoquine) Anti-Malarial Drug

DEPT OF DEFENSE United States has Released a tender for Notice Of Intent To Sole Source - Commercial Packaging And Validation For The Arakoda (Tafenoquine) Anti-Malarial Drug in Pharmaceuticals. The tender was released on Apr 27, 2024.

Country - United States

Summary - Notice Of Intent To Sole Source - Commercial Packaging And Validation For The Arakoda (Tafenoquine) Anti-Malarial Drug

Deadline - login to view

GT reference number - 81331403

Product classification - Business services: law, marketing, consulting, recruitment, printing and security

Organization Details:

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 81331403

  Document Type - Tender Notices

Notice Details and Documents:

Description - Notice of Intent to Sole Source The United States Army Medical Research Acquisition Activity (USAMRAA), on behalf of the United States Army Medical Materiel Development Activity (USAMMDA) is issuing this notice of intent to award a new contract on a sole source basis. This is not a request for proposals. This notice does not represent a commitment by the Government to pay for costs incurred from the preparation and/or submission of data in response to this notice. The Government intends to award a sole source contract, in accordance with FAR 6.302-1(a)(2), to 60 Degrees Pharmaceuticals, Incorporated (60P), 1025 Connecticut Ave, STE 1000, Washington, D.C. 20036-5417. This is a new contract fo

Gt Ref Id - 81331403

Deadline - May 10, 2024

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database